MYOMO INC. NEW DL-,0001

MYOMO INC. NEW DL-,0001 Share · US62857J2015 · MYO · A2PZCL (XASE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MYOMO INC. NEW DL-,0001
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
7
1
0
0
No Price
Closing Price XASE 01.05.2026: 0,90 USD
01.05.2026 23:55
Current Prices from MYOMO INC. NEW DL-,0001
ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
MYO
USD
01.05.2026 23:55
0,92 USD
0,05 USD
+5,49 %
IEXG: IEX
IEX
MYO
USD
01.05.2026 19:59
0,89 USD
0,03 USD
+2,96 %
XASE: AMEX
AMEX
MYO
USD
01.05.2026 19:58
0,90 USD
0,03 USD
+3,25 %
XDQU: Quotrix
Quotrix
MIRSDL15.DUSD
EUR
30.04.2026 17:33
0,73 EUR
0,002 EUR
+0,28 %
XDUS: Düsseldorf
Düsseldorf
MIRSDL15.DUSB
EUR
30.04.2026 17:30
0,70 EUR
-0,02 EUR
-3,18 %
XHAM: Hamburg
Hamburg
MIRSDL15.HAMB
EUR
30.04.2026 06:07
0,68 EUR
-
ESG Risk Rating
B- Good
Share Float & Liquidity
Free Float 91,94 %
Shares Float 35,41 M
Shares Outstanding 38,51 M
Company Profile for MYOMO INC. NEW DL-,0001 Share
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Company Data

Name MYOMO INC. NEW DL-,0001
Company Myomo, Inc.
Symbol MYO
Website https://www.myomo.com
Primary Exchange XASE Frankfurt
WKN A2PZCL
ISIN US62857J2015
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Paul R. Gudonis
Market Capitalization 35 Mio
Country United States of America
Currency EUR
Employees 0,2 T
Address 137 Portland Street, 02114 Boston
IPO Date 2017-06-12

Stock Splits

Date Split
31.01.2020 1:30

Ticker Symbols

Name Symbol
Düsseldorf MIRSDL15.DUSB
Frankfurt 0M61.F
Hamburg MIRSDL15.HAMB
NYSE MYO
Quotrix MIRSDL15.DUSD
More Shares
Investors who hold MYOMO INC. NEW DL-,0001 also have the following shares in their portfolio:
M.B.INT.FIN. 24/27 MTN
M.B.INT.FIN. 24/27 MTN Bond
The 2023 ETF Series Trust Pictet AI & Automation ETF
The 2023 ETF Series Trust Pictet AI & Automation ETF ETF